首页|药物治疗老视的研究进展

药物治疗老视的研究进展

扫码查看
老视是一种生理性退化性疾病,主要表现为近视力下降,影响个人视近功能和生活质量.随着社会人口老龄化日益严峻,老视在世界范围内的患病率不断上升.目前治疗老视的方式包括佩戴眼镜、屈光手术和晶状体手术,但这些治疗手段都存在一定缺陷,作为一种新型,非侵入性的治疗方式,已有相关研究证实药物可以在一定程度上改善老视患者的视近能力.目前治疗老视的药物主要包括缩瞳剂、晶状体软化剂及中药制剂.本文就药物治疗老视的研究进展进行综述.
Research progress in drug treatment of presbyopia
Presbyopia is a physiologic degenerative disease,which is mainly manifested by the decrease of near vi-sion,affecting the near vision function and quality of life of individuals.With the aging of the social population,the preva-lence of presbyopia is increasing worldwide.At present,the treatment of presbyopia includes wearing glasses,refractive surgery and lens surgery,but these treatments all have certain defects.As a new,non-invasive treatment,relevant studies have confirmed that drugs can improve the nearsightedness of presbyopia patients to a certain extent.At present,the main drugs for the treatment of presbyopia include pupil shrinking agents,lens softeners and traditional Chinese medicine prepa-rations.This article reviews the research progress of drug treatment of presbyopia.

PresbyopiaDrug treatmentModulation capacity

石佳宁、孙吉君、王婷

展开 >

264003 滨州,滨州医学院

State Key Laboratory Cultivation Base,Shandong Key Laboratory of Eye Diseases

250021 济南,山东省眼部疾病重点实验室-省部共建国家重点实验室培育基地山东第一医科大学附属眼科医院(山东省眼科医院)

老视 药物治疗 节能力

2024

临床眼科杂志
安徽医科大学,安徽眼科研究所

临床眼科杂志

CSTPCD
影响因子:0.791
ISSN:1006-8422
年,卷(期):2024.32(6)